Breaking News Instant updates and real-time market news.

NYMT

New York Mortgage

$2.03 /

+0.09 (+4.65%)

16:09
05/21/20
05/21
16:09
05/21/20
16:09

New York Mortgage reports Q1 EPS ($1.71), consensus 13c

Steven Mumma, Chairman and Chief Executive Officer, commented: "The global COVID-19 pandemic led to unprecedented market conditions late in the first quarter. As a result, we took decisive action in the latter half of March to improve our liquidity and reduce our exposure to mark-to-market financing counterparties, selling $2.0 billion in assets and reducing our repurchase agreement financings by $1.7 billion from year end-levels. We finished the quarter with $173 million in cash liquidity and a portfolio leverage ratio of 0.7 times. These actions to improve our liquidity did come at a significant cost, as the Company had its worst quarter in its history, seeing its book value drop by 33% and temporarily suspending its quarterly dividends. We believe these actions have better positioned the Company to weather the ongoing economic storm caused by the pandemic and to recover some of the $300 million of net unrealized losses on our balance sheet and deliver the results our stockholders expect." Jason Serrano, President, commented: "Today, with approximately $200 million of unrestricted cash, $1.5 billion of unencumbered investment portfolio and a market leading low leverage ratio under 1 times, we are positioned to take advantage of an extremely dislocated investment landscape, while also finalizing term financing initiatives to further reduce our mark-to-market exposure."

  • 22

    May

NYMT New York Mortgage
$2.03 /

+0.09 (+4.65%)

04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
03/25/20 Maxim
AGNC Investment, New York Mortgage Trust cut to Hold at Maxim
03/25/20 Maxim
New York Mortgage downgraded to Hold from Buy at Maxim

TODAY'S FREE FLY STORIES

Periodicals
USB creates new global financing team, Reuters reports » 17:52
05/25/20
05/25
17:52
05/25/20
17:52
UBS

UBS

$9.82 /

-0.2 (-2.00%)

UBS said on Monday it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$9.82 /

-0.2 (-2.00%)

UBS UBS
$9.82 /

-0.2 (-2.00%)

05/06/20 Deutsche Bank
UBS price target raised to CHF 10 from CHF 9 at Deutsche Bank
05/04/20 Morgan Stanley
UBS price target raised to CHF 11 from CHF 10 at Morgan Stanley
05/04/20 Berenberg
UBS downgraded to Hold from Buy at Berenberg
04/29/20 RBC Capital
UBS price target raised to CHF 11 from CHF 10 at RBC Capital
UBS UBS
$9.82 /

-0.2 (-2.00%)

UBS UBS
$9.82 /

-0.2 (-2.00%)

UBS UBS
$9.82 /

-0.2 (-2.00%)

Periodicals
Toyota, Nissan, Honda gear up for Mexico reboot, Reuters reports » 17:49
05/25/20
05/25
17:49
05/25/20
17:49
TM

Toyota

$117.51 /

-0.655 (-0.55%)

, NSANY

Nissan

$0.00 /

+ (+0.00%)

, HMC

Honda

$23.60 /

-0.11 (-0.46%)

Toyota (TM), Nissan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TM Toyota
$117.51 /

-0.655 (-0.55%)

NSANY Nissan
$0.00 /

+ (+0.00%)

HMC Honda
$23.60 /

-0.11 (-0.46%)

TM Toyota
$117.51 /

-0.655 (-0.55%)

03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
03/30/20 UBS
Toyota upgraded to Buy from Neutral at UBS
02/26/20
Fly Intel: Top five analyst downgrades
02/26/20 JPMorgan
Toyota downgraded to Neutral from Overweight at JPMorgan
NSANY Nissan
$0.00 /

+ (+0.00%)

03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
03/30/20 UBS
Nissan downgraded to Sell from Buy at UBS
01/02/20 Evercore ISI
Renault downgraded to Underperform from In Line at Evercore ISI
06/05/19 UBS
Nissan upgraded to Buy from Sell at UBS
HMC Honda
$23.60 /

-0.11 (-0.46%)

05/12/20 CLSA
Honda downgraded to Underperform from Outperform at CLSA
04/13/20 Goldman Sachs
Honda upgraded to Buy from Neutral at Goldman Sachs
03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
03/30/20 UBS
Honda upgraded to Buy from Neutral at UBS
TM Toyota
$117.51 /

-0.655 (-0.55%)

HMC Honda
$23.60 /

-0.11 (-0.46%)

TM Toyota
$117.51 /

-0.655 (-0.55%)

NSANY Nissan
$0.00 /

+ (+0.00%)

HMC Honda
$23.60 /

-0.11 (-0.46%)

TM Toyota
$117.51 /

-0.655 (-0.55%)

NSANY Nissan
$0.00 /

+ (+0.00%)

HMC Honda
$23.60 /

-0.11 (-0.46%)

Periodicals
Volkswagen Mexico not talking of restart with state decree in place,Reuters says » 17:47
05/25/20
05/25
17:47
05/25/20
17:47
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen said it had…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

04/30/20 JPMorgan
Volkswagen price target raised to EUR 150 from EUR 116 at JPMorgan
03/26/20 RBC Capital
Volkswagen price target raised to EUR 175 from EUR 165 at RBC Capital
03/17/20 Baird
Baird says 'great opportunity' to get back involved with Navistar
03/09/20 Cowen
Cowen upgrades Paccar to Market Perform on 'flight to quality'
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

Periodicals
Minister says Germany still in talks over Lufthansa bailout, Reuters reports » 17:40
05/25/20
05/25
17:40
05/25/20
17:40
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

Germany is still in talks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
04/24/20 Societe Generale
Lufthansa double downgraded to Sell at Societe Generale
04/24/20 Societe Generale
Lufthansa downgraded to Sell from Buy at Societe Generale
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Conference/Events
EverQuote participates in a conference call with Canaccord Genuity » 17:24
05/25/20
05/25
17:24
05/25/20
17:24
EVER

EverQuote

$49.00 /

-0.24 (-0.49%)

Internet Analyst Graham…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

05/05/20 Needham
EverQuote price target raised to $55 from $45 at Needham
05/05/20 Canaccord
EverQuote price target raised to $50 from $48 at Canaccord
02/27/20 JMP Securities
EverQuote price target raised to $50 from $35 at JMP Securities
02/26/20 BofA
EverQuote downgraded to Neutral from Buy at BofA
EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

Hot Stocks
Novavax initiates Phase 1/2 clinical trial of COVID-19 vaccine » 17:02
05/25/20
05/25
17:02
05/25/20
17:02
NVAX

Novavax

$46.14 /

-3.975 (-7.93%)

Novavax announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$46.14 /

-3.975 (-7.93%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
NVAX Novavax
$46.14 /

-3.975 (-7.93%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

NVAX Novavax
$46.14 /

-3.975 (-7.93%)

Hot Stocks
Village Farms' Pure Sunfarms to being roll out of vape products this summer » 16:59
05/25/20
05/25
16:59
05/25/20
16:59
VFF

Village Farms

$5.19 /

+0.94 (+22.12%)

Village Farms announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VFF Village Farms
$5.19 /

+0.94 (+22.12%)

VFF Village Farms
$5.19 /

+0.94 (+22.12%)

05/19/20 Stifel
Village Farms price target lowered to C$15 from C$20 at Stifel
04/02/20 Craig-Hallum
Village Farms price target lowered to $10 from $15 at Craig-Hallum
04/02/20 Roth Capital
Village Farms price target lowered to $10 from $16 at Roth Capital
02/11/20 Craig-Hallum
Village Farms price target lowered to $15 from $20 at Craig-Hallum
VFF Village Farms
$5.19 /

+0.94 (+22.12%)

Hot Stocks
Vermilion Energy announces CEO departure, appoints new President » 16:49
05/25/20
05/25
16:49
05/25/20
16:49
VET

Vermilion Energy

$5.10 /

-0.145 (-2.76%)

Vermilion Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VET Vermilion Energy
$5.10 /

-0.145 (-2.76%)

VET Vermilion Energy
$5.10 /

-0.145 (-2.76%)

05/21/20 CIBC
Vermilion Energy price target raised to C$7 from C$6 at CIBC
04/30/20 CIBC
Vermilion Energy upgraded to Neutral from Underperformer at CIBC
04/23/20 National Bank
Vermilion Energy upgraded to Sector Perform from Underperform at National Bank
03/25/20 Credit Suisse
Vermilion Energy price target lowered to C$5 from C$23 at Credit Suisse
VET Vermilion Energy
$5.10 /

-0.145 (-2.76%)

VET Vermilion Energy
$5.10 /

-0.145 (-2.76%)

Hot Stocks
Teva presents data evaluating AJOVY experience in difficult-to-treat migraine » 16:38
05/25/20
05/25
16:38
05/25/20
16:38
TEVA

Teva

$11.97 /

-0.05 (-0.42%)

Teva Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

05/11/20 UBS
Teva price target raised to ILS 15 from ILS 12 at UBS
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Teva initiated with a Neutral at Citi
04/06/20 UBS
Teva upgraded to Buy from Neutral at UBS
TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

TEVA Teva
$11.97 /

-0.05 (-0.42%)

Hot Stocks
Churchill Downs, Aristocrat announce agreement in principle to settle lawsuits » 16:33
05/25/20
05/25
16:33
05/25/20
16:33
CHDN

Churchill Downs

$122.35 /

+4.15 (+3.51%)

, ARLUF

Aristocrat Leisure

$0.00 /

+ (+0.00%)

Churchill Downs (CHDN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
03/02/20 JPMorgan
Golden Entertainment downgraded to Neutral on downside risk at JPMorgan
03/02/20 JPMorgan
JPMorgan upgrades Churchill Downs on overblown COVID-19 concerns
03/02/20 JPMorgan
Churchill Downs upgraded to Overweight from Neutral at JPMorgan
ARLUF Aristocrat Leisure
$0.00 /

+ (+0.00%)

03/29/20 Goldman Sachs
Aristocrat Leisure upgraded to Buy from Neutral at Goldman Sachs
03/02/20 Credit Suisse
Aristocrat Leisure upgraded to Outperform from Neutral at Credit Suisse
10/28/19 Credit Suisse
Aristocrat Leisure downgraded to Neutral from Outperform at Credit Suisse
CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

CHDN Churchill Downs
$122.35 /

+4.15 (+3.51%)

Hot Stocks
Regeneron to repurchase $5B of shares directly from Sanofi » 13:49
05/25/20
05/25
13:49
05/25/20
13:49
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Regeneron Pharmaceuticals…

Regeneron Pharmaceuticals (REGN) announced that subject to and immediately following the close of its secondary offering, Regeneron agreed to repurchase approximately $5B of common stock directly from Sanofi (SNY). The purchase price to be paid by Regeneron will be equal to the net offering price per share after deducting any underwriters' discount and commission. Regeneron will fund the purchase with a combination of $3.5B of cash on hand and $1.5 billion of fully-committed bridge financing from Goldman Sachs Bank USA.

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Syndicate
Regeneron announces secondary offering for Sanofi sale of 12.8M shares » 13:48
05/25/20
05/25
13:48
05/25/20
13:48
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Hot Stocks
Sanofi to sell investment in Regeneron, says will not impact collaboration » 13:45
05/25/20
05/25
13:45
05/25/20
13:45
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

Sanofi (SNY) announced…

Sanofi (SNY) announced its intent to sell its equity investment in Regeneron Pharmaceuticals (REGN) through a registered public offering and related share repurchase by Regeneron. The registered offering and share repurchase will have no impact on the ongoing collaboration between Sanofi and Regeneron, the company said in a statement. A preliminary prospectus supplement relating to the offering of Regeneron's shares will be filed with the SEC. Sanofi currently holds approximately 23.2M shares of Regeneron's common stock, representing approximately 20.6% ownership. Regeneron has agreed to repurchase $5B of its stock from Sanofi conditional on completion of the proposed public offering. If the offering and repurchase are completed and the underwriters fully exercise their option to purchase additional shares, Sanofi will continue to own approximately 400,000 shares of Regeneron's common stock, which Sanofi is retaining in support of the ongoing collaboration with Regeneron. "Sanofi and Regeneron's collaboration has been one of the most productive in the industry, creating significant value for both companies but more importantly, resulting in five important medicines for patients. Sanofi remains committed to continuing our collaboration with Regeneron which remains an integral part of our overall strategy, and this decision was fully aligned with Regeneron, said Paul Hudson, Chief Executive Officer, Sanofi. "The decision to divest our holdings is consistent with our efforts to enhance value creation for our shareholders. We believe the proceeds from this transaction will help further our ability to execute on our strategy to drive innovation and growth."

ShowHide Related Items >><<
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

General news
U.S. Week Ahead » 11:35
05/25/20
05/25
11:35
05/25/20
11:35

U.S. Week Ahead: Growth,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Oil Action: July WTI futures are up 0.5% » 09:55
05/25/20
05/25
09:55
05/25/20
09:55

Oil Action: July WTI…

Oil Action: July WTI futures are up 0.5% at $33.43, which is just over 30 cents below the intraday high. The market is consolidating recent gains after prices peaked last week at a near-11-week high at $34.66, which was the culmination of four consecutive up weeks. Market conditions are thin in the absence of London markets today, and with U.S. markets closed. An FT on a report detailed a sharp drop in U.S. oil output, with further declines expected later in 2020, with many oil mining operations there having been rendered unviable at prevailing prices. This chimes with last Friday's weekly Baker-Hughes rig count, which revealed another 21 oil rigs were shuttered in the U.S., to bring the the tally to 237 after what is now the 10th straight week of closures. Recent dips in oil inventories have also illustrated shifting fundamentals, with reopening economies around the world stimulating more demand, just as supply continues to ebb.

Recommendations
AMC Networks price target lowered to $28 from $35 at Goldman Sachs » 08:34
05/25/20
05/25
08:34
05/25/20
08:34
AMCX

AMC Networks

$29.11 /

-1.63 (-5.30%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

05/19/20 Imperial Capital
Hard to believe strategic buyer interested in AMC Networks, says Imperial
04/27/20 RBC Capital
AMC Networks initiated with an Outperform at RBC Capital
04/24/20 Imperial Capital
AMC Networks price target lowered to $25 from $33 at Imperial Capital
02/27/20 Wells Fargo
AMC Networks price target lowered to $35 from $46 at Wells Fargo
AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

AMCX AMC Networks
$29.11 /

-1.63 (-5.30%)

Upgrade
KDDI upgraded to Neutral from Sell at Citi » 08:31
05/25/20
05/25
08:31
05/25/20
08:31
KDDIY

KDDI

$0.00 /

+ (+0.00%)

Citi upgraded KDDI to…

Citi upgraded KDDI to Neutral from Sell with a 3,100 yen price target.

ShowHide Related Items >><<
KDDIY KDDI
$0.00 /

+ (+0.00%)

KDDIY KDDI
$0.00 /

+ (+0.00%)

03/17/20 Deutsche Bank
KDDI upgraded to Buy from Hold at Deutsche Bank
12/19/19 JPMorgan
KDDI upgraded to Overweight from Neutral at JPMorgan
06/18/19 JPMorgan
KDDI upgraded to Neutral from Underweight at JPMorgan
KDDIY KDDI
$0.00 /

+ (+0.00%)

Downgrade
Pinduoduo downgraded to Hold from Buy at Jefferies » 08:31
05/25/20
05/25
08:31
05/25/20
08:31
PDD

Pinduoduo

$68.72 /

+8.68 (+14.46%)

Jefferies analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

05/24/20 Goldman Sachs
Pinduoduo downgraded to Neutral from Buy at Goldman Sachs
05/22/20 CLSA
Pinduoduo price target raised to $72 from $46.50 at CLSA
05/20/20 BofA
Pinduoduo downgraded to Neutral from Buy at BofA
04/29/20 KeyBanc
Pinduoduo price target raised to $65 from $50 at KeyBanc
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

Upgrade
Telekom Malaysia upgraded to Outperform from Underperform at Credit Suisse » 08:28
05/25/20
05/25
08:28
05/25/20
08:28
MYTEF

Telekom Malaysia

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Credit Suisse analyst Danny Chen double upgraded Telekom Malaysia to Outperform from Underperform with a MYR 5.50 price target.

Upgrade
Insurance Australia upgraded to Outperform from Neutral at Credit Suisse » 08:25
05/25/20
05/25
08:25
05/25/20
08:25
IAUGY

Insurance Australia

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Canadian Utilities upgraded to Buy from Hold at Industrial Alliance » 08:24
05/25/20
05/25
08:24
05/25/20
08:24
CDUAF

Canadian Utilities

$0.00 /

+ (+0.00%)

Industrial Alliance…

Industrial Alliance analyst Elias Foscolos upgraded Canadian Utilities to Buy from Hold with a C$36 price target.

ShowHide Related Items >><<
CDUAF Canadian Utilities
$0.00 /

+ (+0.00%)

CDUAF Canadian Utilities
$0.00 /

+ (+0.00%)

05/04/20 BMO Capital
Canadian Utilities price target lowered to C$35 from C$36 at BMO Capital
04/23/20 Credit Suisse
Canadian Utilities downgraded to Neutral from Outperform at Credit Suisse
03/31/20 TD Securities
Canadian Utilities upgraded to Buy from Hold at TD Securities
11/01/19 TD Securities
Canadian Utilities downgraded to Hold from Buy at TD Securities
Upgrade
TC Energy upgraded to Buy from Hold at Industrial Alliance » 08:23
05/25/20
05/25
08:23
05/25/20
08:23
TRP

TC Energy

$42.13 /

+0.61 (+1.47%)

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$42.13 /

+0.61 (+1.47%)

TRP TC Energy
$42.13 /

+0.61 (+1.47%)

05/13/20
Fly Intel: Top five analyst downgrades
05/12/20 BMO Capital
TC Energy downgraded to Market Perform from Outperform at BMO Capital
05/12/20
Fly Intel: Top five analyst initiations
05/12/20 Jefferies
TC Energy initiated with a Hold at Jefferies
TRP TC Energy
$42.13 /

+0.61 (+1.47%)

TRP TC Energy
$42.13 /

+0.61 (+1.47%)

Downgrade
Parkland downgraded to Hold from Buy at Industrial Alliance » 08:23
05/25/20
05/25
08:23
05/25/20
08:23
PKIUF

Parkland

$0.00 /

+ (+0.00%)

Industrial Alliance…

Industrial Alliance analyst Elias Foscolos downgraded Parkland to Hold from Buy with a C$40 price target.

ShowHide Related Items >><<
PKIUF Parkland
$0.00 /

+ (+0.00%)

PKIUF Parkland
$0.00 /

+ (+0.00%)

05/08/20 Scotiabank
Parkland Fuel price target lowered to C$40 from C$42 at Scotiabank
05/07/20 RBC Capital
Parkland Fuel price target raised to C$38 from C$35 at RBC Capital
03/24/20 RBC Capital
Parkland Fuel price target lowered to C$35 from C$46 at RBC Capital
03/09/20 BMO Capital
Parkland Fuel attractive after stock decline, says BMO Capital
Upgrade
FirstService upgraded to Buy from Hold at TD Securities » 08:20
05/25/20
05/25
08:20
05/25/20
08:20
FSV

FirstService

$87.40 /

-0.61 (-0.69%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSV FirstService
$87.40 /

-0.61 (-0.69%)

FSV FirstService
$87.40 /

-0.61 (-0.69%)

04/27/20 RBC Capital
FirstService price target lowered to $95 from $112 at RBC Capital
04/24/20
Fly Intel: Top five analyst upgrades
04/24/20 William Blair
FirstService upgraded to Outperform from Market Perform at William Blair
04/23/20 William Blair
FirstService upgraded to Outperform from Market Perform at William Blair
FSV FirstService
$87.40 /

-0.61 (-0.69%)

Initiation
Tabcorp initiated with a Sell at Citi » 08:18
05/25/20
05/25
08:18
05/25/20
08:18
TACBY

Tabcorp

$0.00 /

+ (+0.00%)

Citi initiated coverage…

Citi initiated coverage of Tabcorp with a Sell rating and A$2.80 price target.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.